DALLAS, June 27, 2024 /PRNewswire/ — Cubhub, the nation’s foremost provider of pediatric homecare software, proudly announces its attainment of SOC 2 Type 2 compliance, marking a significant milestone in its dedication to safeguarding customer data and enhancing user satisfaction. This achievement underscores Cubhub’s unwavering commitment to upholding the highest standards of security and confidentiality within its cutting-edge homecare technology solutions.
SOC 2 Type 2 compliance is a certification awarded to organizations that demonstrate exemplary controls and safeguards for protecting customer data. By adhering to the rigorous criteria set forth by the American Institute of Certified Public Accountants (AICPA), Cubhub assures its customers of the stringent security measures in place.
Key benefits of SOC 2 Type 2 compliance for Cubhub’s Medicaid-based clients include:
Cole Ballweg, CEO of Cubhub, commented, “At Cubhub, trust is foundational to our customer relationships. Achieving SOC 2 Type 2 compliance affirms our steadfast commitment to security, privacy, and reliability. It reinforces our belief that everyone benefits when their software partner operates with integrity.”
About Cubhub
Cubhub provides state-of-the-art software solutions tailored for Medicaid-based home health care, driving innovation that revolutionizes business operations for our clients. Committed to empowering agencies with automation tools that enhance efficiency and prioritize patient care, Cubhub continues to set new standards in the industry. Discover how Cubhub can transform your home care agency at www.cubhub.io.
Media Contact: Presley Perkins, presley@cubhubsystems.com
SOURCE Cubhub Systems
Guests had an opportunity to meet Gabby Thomas, win health-focused prizes, and learn simple ways…
NEW YORK CITY, NY / ACCESS Newswire / January 10, 2026 / The phrase best…
CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…
Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…
Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…
Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…